JB Chemicals and Pharmaceuticals last traded at ₹2,408.90 (2026-10-13). Over the past month the stock moved -0.1%, three months the stock moved +10.1%, year the stock moved +40.5%. Its closing range over 52 weeks is ₹1,680.15 – ₹2,412.25, with the latest close 0.1% below the high.
Closing prices up to 2026-10-13.
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]
Change in Management[1] Torrent Pharmaceuticals Ltd. acquired control of the company through share purchase agreements executed in Jun and Jul'25, followed by an open offer under SEBI takeover regulations. The acquisition was completed in Jan and Feb'26, after which Torrent Pharma became the promoter of the company with a 48.8% equity stake as of Mar'26.
In the latest quarter (Mar 2026), JB Chemicals and Pharmaceuticals reported sales of ₹904.00 crore (-4.7%) and net profit of ₹101.00 crore (-30.8%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 904.00 | 201.00 | 22.00 | 101.00 | 6.31 |
| Dec 2025 | 1,065 | 296.00 | 28.00 | 198.00 | 12.63 |
| Sep 2025 | 1,085 | 310.00 | 29.00 | 208.00 | 13.27 |
| Jun 2025 | 1,094 | 301.00 | 28.00 | 202.00 | 12.96 |
| Mar 2025 | 949.00 | 226.00 | 24.00 | 146.00 | 9.36 |
| Dec 2024 | 963.00 | 255.00 | 26.00 | 162.00 | 10.45 |
| Sep 2024 | 1,001 | 271.00 | 27.00 | 175.00 | 11.24 |
| Jun 2024 | 1,004 | 280.00 | 28.00 | 177.00 | 11.39 |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +12.1% | +13.5% | +14.0% | +10.1% | +9.0% | +8.4% | +10.6% | -4.7% |
| Operating profit growth | +20.7% | +11.1% | +14.3% | +14.1% | +7.5% | +14.4% | +16.1% | -11.1% |
| Net profit growth | +24.6% | +15.9% | +20.9% | +15.9% | +14.1% | +18.9% | +22.2% | -30.8% |
| EPS growth | +23.9% | +15.6% | +21.2% | +15.1% | +13.8% | +18.1% | +20.9% | -32.6% |
| OPM % | 28.0% | 27.0% | 26.0% | 24.0% | 28.0% | 29.0% | 28.0% | 22.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), JB Chemicals and Pharmaceuticals reported sales of ₹4,148.00 crore (+5.9%) and net profit of ₹709.00 crore (+7.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4,148 | 1,107 | 27.00 | 709.00 | 44.19 |
| Mar 2025 | 3,918 | 1,032 | 26.00 | 660.00 | 42.37 |
| Mar 2024 | 3,484 | 897.00 | 26.00 | 553.00 | 35.61 |
| Mar 2023 | 3,149 | 696.00 | 22.00 | 410.00 | 26.48 |
| Mar 2022 | 2,424 | 543.00 | 22.00 | 386.00 | 24.93 |
| Mar 2021 | 2,043 | 560.00 | 27.00 | 449.00 | 28.98 |
| Mar 2020 | 1,775 | 378.00 | 21.00 | 272.00 | 17.60 |
| Mar 2019 | 1,643 | 306.00 | 19.00 | 194.00 | 12.05 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +16.7% | +8.0% | +15.1% | +18.6% | +29.9% | +10.6% | +12.5% | +5.9% |
| Operating profit growth | +40.4% | +23.5% | +48.1% | -3.0% | +28.2% | +28.9% | +15.1% | +7.3% |
| Net profit growth | +39.6% | +40.2% | +65.1% | -14.0% | +6.2% | +34.9% | +19.3% | +7.4% |
| EPS growth | +45.5% | +46.1% | +64.7% | -14.0% | +6.2% | +34.5% | +19.0% | +4.3% |
| OPM % | 19.0% | 21.0% | 27.0% | 22.0% | 22.0% | 26.0% | 26.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for JB Chemicals and Pharmaceuticals.
Get Free AI Stock Analysis FREE →No recent news available for JB Chemicals and Pharmaceuticals.
JB Chemicals and Pharmaceuticals shares were last quoted at ₹2,408.90 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
JB Chemicals and Pharmaceuticals has a price-to-earnings (P/E) ratio of 54.59 and a price-to-book (P/B) ratio of 9.31. The industry P/E is 53.45.
The 52-week high of JB Chemicals and Pharmaceuticals is ₹2,509.40 and the 52-week low is ₹1,603.05.
The market capitalisation of JB Chemicals and Pharmaceuticals is about ₹38,730.77 crore.
In the latest quarter (Mar 2026), JB Chemicals and Pharmaceuticals reported sales of ₹904.00 crore (-4.7%) and net profit of ₹101.00 crore (-30.8%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, JB Chemicals and Pharmaceuticals has a 3-year ROE of 19.00%, 3-year profit growth of 21.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 48.80% of JB Chemicals and Pharmaceuticals.
JB Chemicals and Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.